Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients

U Solzbach1, B Hornig, M Jeserich

  • 1Medical Clinic, Department of Cardiology, University of Freiburg, Germany.

Circulation
|October 7, 1997
PubMed

Insights

Vitamin C supplementation improved coronary artery function in hypertensive patients by reducing vasoconstriction and enhancing vasodilation. This suggests that oxidative stress contributes to endothelial dysfunction in hypertension.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Nutritional Science

Background:

  • Hypertension is linked to increased free radical formation, potentially impairing nitric oxide (NO) function and coronary endothelial health.
  • Oxidative stress may inactivate NO, leading to endothelial dysfunction in hypertensive individuals.

Purpose of the Study:

  • To investigate if the antioxidant vitamin C can improve endothelial function in the coronary arteries of patients with hypertension.
  • To test the hypothesis that vitamin C can counteract the negative effects of oxidative stress on vascular function in hypertension.

Main Methods:

  • 22 hypertensive patients without coronary artery disease underwent assessment of endothelium-dependent responses in the left anterior descending coronary artery (LAD).
  • Vascular responses to acetylcholine and flow-dependent vasodilation (FDD) were measured before and after intravenous vitamin C or placebo infusion.
  • Quantitative coronary angiography was used to analyze changes in LAD luminal area.

Main Results:

  • Vitamin C significantly reduced the vasoconstrictor response to acetylcholine in hypertensive patients.
  • Vitamin C significantly augmented flow-dependent vasodilation (FDD) in the coronary arteries.
  • No significant effects of vitamin C were observed on Doppler flow velocity.

Conclusions:

  • Vitamin C administration enhances the endothelium-dependent vasomotor capacity of coronary arteries in hypertensive individuals.
  • The findings support the role of increased oxidative stress in causing endothelial dysfunction among patients with hypertension.
Abstract

Related Concept Videos

Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...